Page 47 - Global Growth Pharmaceuticals & Biotech Stocks

UPDATED Sep 10, 2025

Discover Global Pharmaceuticals & Biotech Growth Stocks from around the world. Sorted by forecasted growth, these Pharmaceuticals & Biotech Stocks have higher than expected earnings or sales growth compared to other companies.

3,050 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield
4516
Nippon Shinyaku
JP¥3,291.000.6%-3.2%JP¥222.3bJP¥3,818.75PE7.3xE-15.6%3.8%
BIOA
BioAge Labs
US$4.821.7%n/aUS$178.5mUS$4.67PS44.7xE-16.0%n/a
OVID
Ovid Therapeutics
US$1.25-6.0%11.6%US$88.2mUS$3.40PS13.4xE-16.0%n/a
AB
AB Science
€1.22-0.5%19.1%€85.4m€2.54PS79.7xE-16.0%n/a
GRI
GRI Bio
US$1.566.8%-82.6%US$3.9mUS$22.00PB1.2xE-16.0%n/a
APGE
Apogee Therapeutics
US$37.49-1.8%-25.9%US$2.3bUS$97.88PB3.5xE-16.2%n/a
MAIA
MAIA Biotechnology
US$1.563.3%-50.2%US$52.5mUS$12.14PB13.3xE-16.4%n/a
CNSP
CNS Pharmaceuticals
US$7.0014.4%-92.6%US$3.8mUS$84.00PB0.3xE-16.5%n/a
ARWR
Arrowhead Pharmaceuticals
US$28.893.9%38.0%US$3.8bUS$46.38PS7xE-16.6%n/a
MGX
Metagenomi
US$1.842.8%-33.8%US$69.8mUS$9.50PS2xE-16.7%n/a
VIVE
Vivesto
SEK 0.23-1.5%-8.5%SEK 123.7mn/aPB0.9xE-16.7%n/a
SYRE
Spyre Therapeutics
US$16.18-3.7%-44.2%US$1.0bUS$53.90PB3.3xE-17.0%n/a
GLMD
Galmed Pharmaceuticals
US$1.419.3%-60.4%US$7.9mn/aPB0.4xE-17.3%n/a
AZTR
Azitra
US$0.77-21.0%-79.4%US$2.7mUS$5.00PB1.2xE-17.4%n/a
SABS
SAB Biotherapeutics
US$2.13-8.2%-23.9%US$22.2mUS$9.20PS193.3xE-17.5%n/a
BIVI
BioVie
US$1.9114.4%-93.4%US$13.5mUS$12.00PB0.8xE-17.6%n/a
SION
Sionna Therapeutics
US$23.47-4.4%n/aUS$1.1bUS$38.00PB3.1xE-17.6%n/a
ANRO
Alto Neuroscience
US$3.56-1.4%-73.5%US$102.1mUS$10.33PB0.8xE-17.7%n/a
NKTR
Nektar Therapeutics
US$48.1868.8%157.0%US$923.7mUS$96.17PS12.2xE-18.1%n/a
TRML
Tourmaline Bio
US$47.6089.6%165.6%US$1.2bUS$48.39PB4.7xE-18.1%n/a
SNTI
Senti Biosciences
US$1.30-10.0%-57.2%US$34.0mUS$13.50PB1.4xE-18.3%n/a
VTVT
vTv Therapeutics
US$19.020.8%31.1%US$134.5mUS$35.50PS7370.6xE-18.5%n/a
CMMB
Chemomab Therapeutics
US$2.99-1.0%-63.2%US$15.8mUS$29.67PB1.6xE-18.8%n/a
CBIO
Crescent Biopharma
US$12.23-7.6%n/aUS$245.3mUS$25.60PE-3.3xE-18.9%n/a
Page 47 of 128